GGrantIndex
Sort

50,496 grants matching lung cancer

Advanced PET/CT Imaging for Improving Clinical Trials

$656,737
Paul E Kinahan · University Of Washington · U01 · FY2016 · CA

Intervention of Pancreatic Oncogenic Pathways with Dietary Tocotrienol

$656,718
Mokenge P. Malafa · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA

Genetic evolution of glioblastomas during radiation and temozolomide therapy

$656,695
Rameen Beroukhim · Dana-Farber Cancer Inst · R01 · FY2019 · CA

Molecular Risk Stratification for Colonoscopic Surveillance

$656,638
Andrew T Chan · Massachusetts General Hospital · U01 · FY2015 · CA

Unraveling the molecular mechanisms of impaired central tolerance in COPA syndrome

$656,632
Anthony Shum · University Of California, San Francisco · R01 · FY2024 · AI

ASPH Targeted Therapy for Chondrosarcoma

$656,612
Richard M Terek · Rhode Island Hospital · R01 · FY2025 · CA

Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research

$656,563
Prem Khovabutr Premsrirut · Mirimus, Inc. · R44 · FY2017 · CA

Tracking Peripheral T-Cell Repertoire Changes for Preoperative and Early Ovarian Cancer Diagnosis

$656,516
Bo Li · Ut Southwestern Medical Center · R01 · FY2022 · CA

CCR FACS Core Laboratory

$656,486
Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

Targeting the transcriptional and epigenetic landscape in chemo-refractory Small-Cell Lung Cancer

$656,426
Kwok Kin Wong · New York University School Of Medicine · U01 · FY2021 · CA

Incorporating Biomarkers to Improve Lung Cancer Risk Prediction

$656,359
Ziding Feng · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA

Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring

$656,329
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2022 · CA

Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring

$656,329
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2023 · CA

Expanding the Utility of Severe Combined Immuno-Deficient (SCID) Pig Models

$656,326
Christopher Tuggle · Iowa State University · R24 · FY2015 · OD

Immunology Team Contributions to the LSB

$656,183
Ronald Germain · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI

Full Spectrum Cell Sorter with Imaging Enhancement for Boston University Flow Cytometry Core Facility

$656,148
Anna Belkina · Boston University Medical Campus · S10 · FY2025 · OD

Centralization of Cancer Care: Implications for Access, Outcomes, and Disparities

$656,146
Bruce L. Jacobs · University Of Pittsburgh At Pittsburgh · R37 · FY2022 · CA

Randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients: Increasing access in underserved rural communities

$656,043
Sharla Maelyn Wells-Di Gregorio · Ohio State University · R01 · FY2025 · CA

Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model

$656,025
Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2011 · CA

Randomized clinical trial of a telemedicine-mHealth symptom cluster intervention for advanced cancer patients: Increasing access in underserved rural communities

$656,014
Sharla Maelyn Wells-Di Gregorio · Ohio State University · R01 · FY2024 · CA

Preclinical Studies on Polyunsaturated Fatty Acid-Taxoid Conjugate for IND Filing

$656,011
Ramesh Chander Gupta · Chem-Master International, Inc · R44 · FY2010 · CA

Core B. Clinical & Biomarkers Core

$656,005
Dorothy K Hatsukami · University Of Minnesota · P01 · FY2024 · CA

Biomarkers to Assess Selenium Chemoprevention for NSCLC

$655,955
Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2006 · CA

Graft extracellular vesicles as promoters of anti-donor immunity in cardiac and skin transplantation

$655,927
Adrian E Morelli · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI

Reducing racial disparities in lung cancer outcomes by decoding neighborhood contextual environment (RECODE)

$655,852
Seijeoung Kim · University Of Illinois At Chicago · R01 · FY2022 · MD